NVS: Novartis AG Stocks News on February 22, 2025

Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds

NVS

Insider Monkey

2 days ago

Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds

BMO Expands Canadian Depositary Receipt (CDR) Lineup with 10 New Listings from Europe and Japan

NVS

CNW Group

2 days ago

BMO Expands Canadian Depositary Receipt (CDR) Lineup with 10 New Listings from Europe and Japan

HMRI and Novartis Australia sign MoU to expedite medical research

NVS

Pharmaceutical Technology

4 days ago

HMRI and Novartis Australia sign MoU to expedite medical research

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

NVS

Zacks

8 days ago

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

Is Novartis AG (NVS) the Best Foreign Dividend Stock to Buy According to Analysts?

NVS

Insider Monkey

8 days ago

Is Novartis AG (NVS) the Best Foreign Dividend Stock to Buy According to Analysts?

Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia

NVS

Pharmaceutical Technology

8 days ago

Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia

NVS

MT Newswires

9 days ago

Novartis Faces 'Sharp Deceleration' in Growth in Mid-2025, UBS Says

Abcuro secures $200m as it eyes approval for rare muscle disease drug

NVS

Pharmaceutical Technology

10 days ago

Abcuro secures $200m as it eyes approval for rare muscle disease drug

NVS

MT Newswires

11 days ago

Sector Update: Health Care Stocks Fall in Late Afternoon Trading

NVS

MT Newswires

11 days ago

Sector Update: Health Care Stocks Softer Tuesday Afternoon

NVS

MT Newswires

11 days ago

Sector Update: Health Care

NVS

MT Newswires

11 days ago

Novartis signs agreement to acquire Anthos for $925m upfront

Novartis Strikes Up to $3.1 Billion Deal to Buy Anthos Therapeutics

NVS

MT Newswires

11 days ago

Novartis Strikes Up to $3.1 Billion Deal to Buy Anthos Therapeutics

Novartis pays $925M to reel in a startup it helped launch

NVS

BioPharma Dive

11 days ago

Novartis pays $925M to reel in a startup it helped launch

NVS

MT Newswires

11 days ago

Novartis to Acquire Anthos Therapeutics for Up to $3.1 Billion

Novartis buys Blackstone's Anthos for up to $3.1 billion

NVS

Reuters

11 days ago

Novartis buys Blackstone's Anthos for up to $3.1 billion

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

NVS

GlobeNewswire

11 days ago

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

Is Novartis AG (NVS) The Best Annual Dividend Stock To Buy Now?

NVS

Insider Monkey

12 days ago

Is Novartis AG (NVS) The Best Annual Dividend Stock To Buy Now?

Novartis and Dawn Health introduce breast cancer support app

NVS

Medical Device Network

16 days ago

Novartis and Dawn Health introduce breast cancer support app

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

NVS

Zacks

16 days ago

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

Novartis Rises 5% Since Q4 Earnings: How Should You Play the Stock?

NVS

Zacks

16 days ago

Novartis Rises 5% Since Q4 Earnings: How Should You Play the Stock?

Pfizer taps former Novartis exec to lead cancer drug push

NVS

BioPharma Dive

16 days ago

Pfizer taps former Novartis exec to lead cancer drug push

Novartis AG (NVS): Among the Best Foreign Dividend Stocks to Invest In Now

NVS

Insider Monkey

17 days ago

Novartis AG (NVS): Among the Best Foreign Dividend Stocks to Invest In Now

Here's Why Novartis (NVS) is a Strong Value Stock

NVS

Zacks

17 days ago

Here's Why Novartis (NVS) is a Strong Value Stock

Radiopharmaceutical deals drive sector growth despite supply crisis

NVS

Pharmaceutical Technology

17 days ago

Radiopharmaceutical deals drive sector growth despite supply crisis

NVS

MT Newswires

18 days ago

Sector Update: Health Care Stocks Decline Tuesday Afternoon

Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know

NVS

Zacks

18 days ago

Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know

NVS

MT Newswires

18 days ago

Market Chatter: Novartis on Lookout for Next-Generation Obesity Drug Candidates

2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond

NVS

Motley Fool

19 days ago

2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond

NVS

Morningstar Research

21 days ago

Analyst Report: Novartis AG

Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ...

NVS

GuruFocus.com

21 days ago

Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ...

Novartis Pares Gains As Its Bread-And-Butter Drug Faces Looming Competition

NVS

Investor's Business Daily

22 days ago

Novartis Pares Gains As Its Bread-And-Butter Drug Faces Looming Competition

Novartis Posts Q4 Earnings and Sales Beat, Shares Gain

NVS

Zacks

22 days ago

Novartis Posts Q4 Earnings and Sales Beat, Shares Gain

NVS

MT Newswires

22 days ago

Ionis Pharmaceuticals Says Data Readout From Pelacarsen Study Is Delayed

Novartis Ag (NVS) Q4 2024 Earnings Call Transcript

NVS

Motley Fool

22 days ago

Novartis Ag (NVS) Q4 2024 Earnings Call Transcript

Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

NVS

Zacks

22 days ago

Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker

NVS

Investor's Business Daily

22 days ago

Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker

NVS

The Wall Street Journal

22 days ago

Health Care Roundup: Market Talk

Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb

NVS

BioPharma Dive

22 days ago

Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb

Novartis Q4 Earnings: Revenue And EPS Beat, CEO Dismisses Entresto Patent Expiration Worries

NVS

Benzinga

22 days ago

Novartis Q4 Earnings: Revenue And EPS Beat, CEO Dismisses Entresto Patent Expiration Worries

NVS

Associated Press Finance

22 days ago

Novartis: Q4 Earnings Snapshot

Novartis Expects Further Profit, Sales Growth Despite Competition Threat

NVS

The Wall Street Journal

22 days ago

Novartis Expects Further Profit, Sales Growth Despite Competition Threat

NVS

MT Newswires

22 days ago

Novartis Q4 Core Earnings, Revenue Rise

Novartis beats Q4 earnings consensus as drug sales surge

NVS

Reuters

22 days ago

Novartis beats Q4 earnings consensus as drug sales surge

Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024

NVS

GlobeNewswire

22 days ago

Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024

Chevron earnings, December PCE, FedSpeak: What to Watch

NVS

Yahoo Finance Video

23 days ago

Chevron earnings, December PCE, FedSpeak: What to Watch

Novartis to Report Q4 Earnings: What's in the Offing?

NVS

Zacks

25 days ago

Novartis to Report Q4 Earnings: What's in the Offing?

Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says

NVS

BioPharma Dive

25 days ago

Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says

After an obesity stumble, BioAge reconnects with its longevity pipeline

NVS

Pharma Voice

a month ago

After an obesity stumble, BioAge reconnects with its longevity pipeline

NVS

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Premarket Friday

NVS

MT Newswires

a month ago

Novartis Obtains Temporary Court Order Blocking Generic Version of Entresto

US appeals court reinstates pause on generic version of Novartis' Entresto

NVS

Reuters

a month ago

US appeals court reinstates pause on generic version of Novartis' Entresto

Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug

NVS

Benzinga

a month ago

Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

NVS

BioPharma Dive

a month ago

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

Novartis wins temporary pause to Entresto generic launch in US

NVS

Reuters

a month ago

Novartis wins temporary pause to Entresto generic launch in US

JP Morgan 2025: Novartis streamlines its portfolio to drive future growth

NVS

Pharmaceutical Technology

a month ago

JP Morgan 2025: Novartis streamlines its portfolio to drive future growth

Broader population could benefit from Novartis spinal muscular atrophy treatment

NVS

Clinical Trials Arena

a month ago

Broader population could benefit from Novartis spinal muscular atrophy treatment

Novartis Entresto® US patent upheld by US Court of Appeals

NVS

GlobeNewswire

a month ago

Novartis Entresto® US patent upheld by US Court of Appeals

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

NVS

Zacks

a month ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

AI, vaccine distrust, & the future of healthcare: Novartis CEO

NVS

Yahoo Finance Video

a month ago

AI, vaccine distrust, & the future of healthcare: Novartis CEO

Light Horse emerges with $62m and Novartis partnership worth up to $1bn

NVS

Pharmaceutical Technology

a month ago

Light Horse emerges with $62m and Novartis partnership worth up to $1bn

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

NVS

Zacks

a month ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Why Novartis (NVS) is a Top Value Stock for the Long-Term

NVS

Zacks

a month ago

Why Novartis (NVS) is a Top Value Stock for the Long-Term

NVS

Zacks

a month ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More

NVS

Zacks

2 months ago

Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More

Positive data could expand use of Novartis’ gene therapy for SMA

NVS

Clinical Trials Arena

2 months ago

Positive data could expand use of Novartis’ gene therapy for SMA

Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals

NVS

BioPharma Dive

2 months ago

Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals

Novartis' Gene Therapy Meets Primary Endpoint in SMA Study

NVS

Zacks

2 months ago

Novartis' Gene Therapy Meets Primary Endpoint in SMA Study

Here's Why Novartis (NVS) is a Strong Growth Stock

NVS

Zacks

2 months ago

Here's Why Novartis (NVS) is a Strong Growth Stock

Novartis’ Gene Therapy Shows Promise in Treating SMA

NVS

TipRanks

2 months ago

Novartis’ Gene Therapy Shows Promise in Treating SMA

Novartis’ Phase III spinal muscular atrophy therapy trial meets primary endpoint

NVS

Clinical Trials Arena

2 months ago

Novartis’ Phase III spinal muscular atrophy therapy trial meets primary endpoint

NVS

MT Newswires

2 months ago

Novartis Says Gene Therapy for Spinal Muscular Atrophy Meets Primary Endpoint in Phase 3 Study

Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA

NVS

GlobeNewswire

2 months ago

Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA

Novartis AG (NVS): Among the Cheap Healthcare Stocks to Buy Heading Into 2025

NVS

Insider Monkey

2 months ago

Novartis AG (NVS): Among the Cheap Healthcare Stocks to Buy Heading Into 2025

NVS

MT Newswires

2 months ago

Sector Update: Health Care Stocks Lower in Late Afternoon Trading

NVS

MT Newswires

2 months ago

Sector Update: Health Care

NVS

MT Newswires

2 months ago

Novartis Must Face Claims Alleging Kickbacks for MS Drug Promotion, US Appeals Court Rules

Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules

NVS

Reuters

2 months ago

Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules

Why Is Novartis AG (NVS) Among the Best European Dividend Stocks To Buy Now?

NVS

Insider Monkey

2 months ago

Why Is Novartis AG (NVS) Among the Best European Dividend Stocks To Buy Now?

Buy 5 Large-Cap Laggards of 2024 Likely to Surge in the Near Term

NVS

Zacks

2 months ago

Buy 5 Large-Cap Laggards of 2024 Likely to Surge in the Near Term

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

NVS

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

NVS

MT Newswires

2 months ago

Update: Novartis to Close MorphoSys Sites, Affecting 330 Jobs

NVS

MT Newswires

2 months ago

Market Chatter: Novartis to Close MorphoSys Sites, Affecting 330 Jobs

Novartis shutters MorphoSys sites, lays off staff

NVS

BioPharma Dive

2 months ago

Novartis shutters MorphoSys sites, lays off staff

BioAge and Novartis seek drug targets for ageing-related diseases

NVS

Pharmaceutical Technology

2 months ago

BioAge and Novartis seek drug targets for ageing-related diseases

Novartis says 330 jobs hit as it closes MorphoSys sites

NVS

Reuters

2 months ago

Novartis says 330 jobs hit as it closes MorphoSys sites

NVS

MT Newswires

2 months ago

BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases

Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations

NVS

Zacks

2 months ago

Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations

Novartis AG (NVS): Among the Oversold Global Stocks to Buy Right Now

NVS

Insider Monkey

2 months ago

Novartis AG (NVS): Among the Oversold Global Stocks to Buy Right Now

NVS vs. LLY: Which Stock Should Value Investors Buy Now?

NVS

Zacks

2 months ago

NVS vs. LLY: Which Stock Should Value Investors Buy Now?

Are Investors Undervaluing Novartis (NVS) Right Now?

NVS

Zacks

2 months ago

Are Investors Undervaluing Novartis (NVS) Right Now?

NVS

Zacks

2 months ago

The Zacks Analyst Blog Mastercard, The Procter & Gamble, Novartis AG, IDT and GSI Technology

Top Stock Reports for Mastercard, Procter & Gamble & Novartis

NVS

Zacks

2 months ago

Top Stock Reports for Mastercard, Procter & Gamble & Novartis

NVS

MT Newswires

2 months ago

Monte Rosa Closes Global License Agreement With Novartis

NVS

MT Newswires

2 months ago

Novartis Says Longer-Term Data Highlight Kisqali's Efficacy as Early Breast Cancer Treatment

Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer

NVS

GlobeNewswire

2 months ago

Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer

Novartis Announces Positive Results From Late-Stage Study on Fabhalta

NVS

Zacks

2 months ago

Novartis Announces Positive Results From Late-Stage Study on Fabhalta

Novartis reports topline outcomes from Phase IIIB PNH trial of Fabhalta

NVS

Clinical Trials Arena

2 months ago

Novartis reports topline outcomes from Phase IIIB PNH trial of Fabhalta

NVS

GlobeNewswire

2 months ago

Latest Novartis AG (NVS) News on February 22, 2025

Share on Social Networks: